Reviewing DIH Holding US (DHAI) & Its Peers

Insider and Institutional Ownership

27.8% of DIH Holding US shares are owned by institutional investors. Comparatively, 47.5% of shares of all “Surgical & medical instruments” companies are owned by institutional investors. 49.6% of DIH Holding US shares are owned by insiders. Comparatively, 15.3% of shares of all “Surgical & medical instruments” companies are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings & Valuation

This table compares DIH Holding US and its rivals gross revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
DIH Holding US	$64.47 million	-$8.44 million	-1.76
DIH Holding US Competitors	$1.01 billion	$76.80 million	-3.84

DIH Holding US’s rivals have higher revenue and earnings than DIH Holding US. DIH Holding US is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk & Volatility

DIH Holding US has a beta of -0.66, indicating that its stock price is 166% less volatile than the S&P 500. Comparatively, DIH Holding US’s rivals have a beta of 1.19, indicating that their average stock price is 19% more volatile than the S&P 500.

Profitability

This table compares DIH Holding US and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
DIH Holding US	-13.59%	-5.07%	-25.01%
DIH Holding US Competitors	-547.12%	-146.67%	-26.51%

Summary

DIH Holding US beats its rivals on 5 of the 9 factors compared.

About DIH Holding US

DIH Holding US, Inc. operates as a robotics and virtual reality (VR) technology provider for the rehabilitation industry in Europe, the Middle East, Africa, the United States, and the Asia Pacific. It offers ArmeoPower, a backbone robot for arm and hand therapy in an early stage of rehabilitation; ArmeoSpring for less severe patients that provides self-initiated repetitive arm and hand therapy in an extensive workspace; ArmeoSpring Pro; and Armeo Senso, for patients self-initiated and still structurally controlled movement patterns to completely open movement. The company also provides lower extremity products, including Erigo for gradual verticalization, leg mobilization, and intensive sensorimotor stimulation through cyclic leg loading; Lokomat, a robot-assisted therapy that enables training to increase the strength of muscles and a range of motion of joints in order to improve walking; Andago, a robotics smart control system that assists patients in walking naturally; C-Mill, creates a training environment; CAREN, a computer assisted rehabilitation environment; and GRAIL, an gait real-time analysis interactive lab solution for analysis training and research. In addition, it offers SafeGait, RYSEN, and M-Gait for gait and balance; and HocoNet and D-Flow software. DIH Holding US, Inc. was founded in 2021 and is based in Norwell, Massachusetts.